We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$95.4B
1-Year Est. Return
38.74%
This Fund
S&P 500
This Quarter
Est. Return
+2.31%
1 Year Est. Return
+38.74%
3 Year Est. Return
+101.74%
5 Year Est. Return
+133.96%
10 Year Est. Return
+604.63%
AUM
$93.9B
AUM Growth
+$6.07B
(+6.9%)
Cap. Flow
-$705M
Cap. Flow
% of AUM
-0.75%
Top 10 Holdings %
Top 10 Hldgs %
10.12%
Holding
2,724
New
225
Increased
1,153
Reduced
856
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fluor
FLR
|
+$224M |
| 2 |
Entergy
ETR
|
+$194M |
| 3 |
General Dynamics
GD
|
+$190M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$147M |
| 5 |
Alibaba
BABA
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$291M |
| 2 |
Valero Energy
VLO
|
+$197M |
| 3 |
Wells Fargo
WFC
|
+$196M |
| 4 |
Apple
AAPL
|
+$193M |
| 5 |
Macy's
M
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.35% |
| 2 | Financials | 10.69% |
| 3 | Healthcare | 9.92% |
| 4 | Industrials | 6.49% |
| 5 | Consumer Discretionary | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Everest Group
EG
$14.5B
| $110M | 0.12% |
602,025
+8,244
| +1% | +$1.52M |
|
177
Coca-Cola
KO
$377B
| $109M | 0.12% |
2,409,328
+140,497
| +6% | +$6.35M |
|
178
Thermo Fisher Scientific
TMO
$213B
| $108M | 0.11% |
728,324
+88,301
| +14% | +$13M |
|
|
179
CALL
Apple
AAPL
$4.54T
| $107M | 0.11% |
4,496,400
+3,277,200
| +269% | +$81.4M |
|
180
International Flavors & Fragrances
IFF
$20.2B
| $107M | 0.11% |
850,765
-12,167
| -1% | -$1.5M |
|
|
ALXN
181
DELISTED
Alexion Pharmaceuticals
ALXN
| $105M | 0.11% |
902,127
-88,137
| -9% | -$12.5M |
|
|
DST
182
DELISTED
DST Systems Inc.
DST
| $104M | 0.11% |
1,791,746
-1,202
| -0.1% | -$70.5K |
|
183
Berkshire Hathaway Class B
BRK.B
$1.1T
| $104M | 0.11% |
720,321
-53,271
| -7% | -$7.62M |
|
184
American Express
AXP
$227B
| $104M | 0.11% |
1,714,434
+200,948
| +13% | +$12.7M |
|
185
PUT
Bristol-Myers Squibb
BMY
$133B
| $104M | 0.11% |
1,414,100
+664,700
| +89% | +$47M |
|
|
AMT.PRA
186
DELISTED
American Tower Corporation
AMT.PRA
| $104M | 0.11% |
923,020
-72,750
| -7% | -$7.81M |
|
187
PUT
Merck
MRK
$322B
| $104M | 0.11% |
1,884,094
+944,457
| +101% | +$50.3M |
|
188
PUT
3M
MMM
$90.9B
| $103M | 0.11% |
703,248
+360,833
| +105% | +$50.9M |
|
|
TSNU
189
DELISTED
Tyson Foods, Inc.
TSNU
| $102M | 0.11% |
1,375,525
-746,000
| -35% | -$53.7M |
|
190
PUT
Intel
INTC
$455B
| $101M | 0.11% |
3,093,700
+1,589,700
| +106% | +$49.8M |
|
|
KMI.PRA
191
DELISTED
Kinder Morgan, Inc.
KMI.PRA
| $99.7M | 0.11% |
2,041,600
+95,000
| +5% | +$4.34M |
|
192
CME Group
CME
$96.3B
| $98.4M | 0.1% |
1,010,315
-210,997
| -17% | -$19.9M |
|
193
Lear
LEA
$6.54B
| $98M | 0.1% |
963,230
+3,033
| +0.3% | +$341K |
|
194
Goldman Sachs
GS
$300B
| $97.9M | 0.1% |
658,986
+52,198
| +9% | +$8.14M |
|
195
PUT
AbbVie
ABBV
$443B
| $97.8M | 0.1% |
1,580,400
+1,032,000
| +188% | +$62.9M |
|
196
Agilent Technologies
A
$39.1B
| $97.7M | 0.1% |
2,201,496
+53,574
| +2% | +$2.31M |
|
197
Ameren
AEE
$30.3B
| $97.2M | 0.1% |
1,814,467
-39,819
| -2% | -$1.96M |
|
198
PUT
SLB Ltd
SLB
$73.6B
| $96.9M | 0.1% |
1,225,700
+623,600
| +104% | +$47.8M |
|
199
Cigna
CI
$73.7B
| $96.9M | 0.1% |
757,202
-81,925
| -10% | -$10.8M |
|
|
CELG
200
PUT
DELISTED
Celgene Corp
CELG
| $96M | 0.1% |
973,600
+495,600
| +104% | +$51.3M |
|
Similar funds
Allianz Asset Management's Q2 2016 Portfolio in Review
As of Q2 2016, Allianz Asset Management held 2,724 positions worth $93.9B, up 6.9% from $87.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Allianz Asset Management's Q2 2016 filing shows 225 new, 1,153 increased, 856 reduced and 182 closed positions. Its largest new stake was S&P Global: 874,259 shares worth $93.8M. The largest sale was Teva Pharmaceuticals, an estimated $291M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
- Allianz Asset Management's largest Q2 2016 buy was S&P Global: 874,259 shares worth $93.8M.
- Allianz Asset Management added most to Fluor in Q2 2016, an estimated $224M increase.
- Allianz Asset Management's biggest Q2 2016 reduction was Teva Pharmaceuticals, cutting an estimated $291M.
- Allianz Asset Management fully exited ATMEL CORP in Q2 2016, selling an estimated $79.4M.
- Allianz Asset Management's ten largest holdings make up 10% of its $93.9B portfolio in Q2 2016.
- Allianz Asset Management opened 225 new positions and closed 182 in Q2 2016.
- Allianz Asset Management's portfolio value rose 6.9% quarter-over-quarter to $93.9B.
Based on Allianz Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.